Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

BACKGROUND: For patients with UC, flexible maintenance dosing therapy may confer advantages for safety, efficacy, costs and patient preference. Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of UC. AIM: To assess the efficacy and safety of tofacitinib dose de‐escalation and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sands, Bruce E., Armuzzi, Alessandro, Marshall, John K., Lindsay, James O., Sandborn, William J., Danese, Silvio, Panés, Julián, Bressler, Brian, Colombel, Jean‐Frédéric, Lawendy, Nervin, Maller, Eric, Zhang, Haiying, Chan, Gary, Salese, Leonardo, Tsilkos, Konstantinos, Marren, Amy, Su, Chinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Efficacy and Safety of Tofacitinib Dose Escalation and De‐escalation in Ulcerative Colitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328429/
https://www.ncbi.nlm.nih.gov/pubmed/31660640
http://dx.doi.org/10.1111/apt.15555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328429/
https://www.ncbi.nlm.nih.gov/pubmed/31660640
http://dx.doi.org/10.1111/apt.15555

Ejemplares similares